15
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T78337 | Mouse IgG2a kappa, Isotype Control | ||
Mouse IgG2a kappa, Isotype Control is an isotype antibody to murine-derived IIgG2a kappa antibody. | |||
T12500 | Platycoside E | Platycodin E | Others |
Platycoside E (Platycodin E) is a platycodigenin-type saponin isolated from the root of Platycodon grandiflorum with haemolytic activity and adjuvant potential. | |||
T78268 | Anti-Mouse NK1.1 Antibody (PK136) | ||
Anti-Mouse NK1.1 Antibody (PK136) is an IgG2a class antibody of murine origin targeting NK1.1, which eliminates NK1.1 and NK1.1NKT cells and inhibits NK1.1 signaling in peripheral blood, spleen, and lung tissues, and can... | |||
T81755 | Mouse lgG2a (D265A) kappa, Isotype Control | ||
Mouse IgG2a (D265A) kappa Isotype Control is a monoclonal antibody serving as an isotype control specifically for the Mouse IgG2a (D265A) antibody. | |||
T80583 | Anti-Mouse 4-1BB Antibody (3H3) | ||
Anti-Mouse 4-1BB Antibody is a rat-derived IgG2a isotype inhibitor targeting the mouse 4-1BB (CD137) protein. | |||
T80585 | Anti-Mouse GM-CSF Antibody (MP1-22E9) | c-Fms | |
Anti-Mouse GM-CSF Antibody is a rat-derived IgG2a isotype inhibitor that targets mouse granulocyte-macrophage colony-stimulating factor (GM-CSF). | |||
T80620 | Anti-Mouse CD19 Antibody (1D3) | ||
Anti-Mouse CD19 Antibody (1D3) is an IgG2a isotype inhibitor targeting mouse CD19. | |||
T78260 | Anti-Mouse CD8a Antibody (53-6.7) | ||
Anti-Mouse CD8a Antibody is a rat-derived IgG2a isotype inhibitor specific for mouse CD8a. | |||
T76835 | Tositumomab | ||
Tositumomab, a murine IgG2a lambda monoclonal antibody, targets the CD20 antigen located on the surface of both normal and malignant B lymphocytes [1]. | |||
T80597 | Dafsolimab | SPV-T3a | |
Dafsolimab (SPV-T3a), an IgG2a murine monoclonal antibody (anti-CD3), induces cell death by modulating and activating the CD3/T cell receptor complex and is utilized in research pertaining to graft-versus-host disease (G... | |||
T76841 | Enlimomab | ||
Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody targeting human ICAM-1, reduces leukocyte adhesion to the vascular endothelium, thus diminishing leukocyte extravasation and inflammatory tissue damage. This com... | |||
T76908 | Anumigilimab | ||
Anumigilimab (CSL-324) is a humanized IgG2a monoclonal antibody (mAb) targeting the human granulocyte colony-stimulating factor (G-CSF) receptor, utilized to elevate neutrophil counts at inflammation sites [1] [2]. | |||
T76680 | Fremanezumab | ||
Fremanezumab (TEV-48125), a humanized IgG2a monoclonal antibody, potently and selectively targets the calcitonin gene-related peptide (CGRP), a 37-amino acid neuropeptide implicated in the central and peripheral mechanis... | |||
T82260 | Grisnilimab | WT1 | |
"Grisnilimab (WT1), an IgG2a monoclonal antibody targeting CD7, acts as a tumor suppressor in the pathogenesis of Wilms' tumor. It modulates the transcription of various genes and may be involved in post-transcriptional ... | |||
T76920 | Bectumomab | ||
Bectumomab (IMMU-LL 2), a humanized IgG2a monoclonal antibody (mAb) against human CD22 (antigen), serves as an anti-lymphoma agent. It is utilized in imaging procedures when combined with technetium 99 (Tc99m LL2 Fab), a... |